Episode Details
Back to Episodes
Oriahnn for Fibroids HMB (New Med Approval)
Published 5 years, 9 months ago
Description
On May 29, 2020, the U.S. FDA approved an novel oral drug, Oriahnn, for HMB use to fibroids. This medication (elagolix, estradiol, and norethindrone acetate) is the first oral medication designed specifically for Fibroid HMB. In this session, we will review this new medication. (No financial disclosures to report).